Genentech BioOncology Co-pay Card
- *If your patient's annual household income is >$100,000, the card limit is reduced. See "How much does the card cover?" below for details.
RITUXAN is not recommended for use in patients with severe, active infections.
WARNING: FATAL INFUSION REACTIONS, SEVERE MUCOCUTANEOUS REACTIONS, HEPATITIS B VIRUS REACTIVATION and PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY
Attention Healthcare Provider: Provide Medication Guide to patient prior to RITUXAN infusion.
You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch.
You may also report side effects to Genentech at (888) 835-2555.
Before you start exploring, take the time to read the BOXED WARNINGS and Additional Important Safety Information.
Roll over to read more